AI vs. cancer: new tool aims to catch deadly uterine tumors earlier
NCT ID NCT07269535
Summary
This study is testing a new AI tool designed to help doctors tell the difference between common, harmless uterine fibroids and a rare but dangerous cancer called uterine sarcoma. The tool analyzes MRI scans to predict which fibroids might turn cancerous. Researchers will enroll 500 women to see if this AI works reliably in real-world clinics to improve early detection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AI (ARTIFICIAL INTELLIGENCE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.